638 related articles for article (PubMed ID: 25913458)
1. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
3. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pang X; Yi Z; Zhang X; Sung B; Qu W; Lian X; Aggarwal BB; Liu M
Cancer Res; 2009 Jul; 69(14):5893-900. PubMed ID: 19567671
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants.
Mei S; Cammalleri M; Azara D; Casini G; Bagnoli P; Dal Monte M
J Pathol; 2012 Feb; 226(3):519-33. PubMed ID: 21960021
[TBL] [Abstract][Full Text] [Related]
6. Curcumolide, a unique sesquiterpenoid from Curcuma wenyujin displays anti-angiogenic activity and attenuates ischemia-induced retinal neovascularization.
Lin W; Tu H; Zhu Y; Guan Y; Liu H; Ling W; Yan P; Dong J
Phytomedicine; 2019 Nov; 64():152923. PubMed ID: 31450226
[TBL] [Abstract][Full Text] [Related]
7. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1.
Kunnumakkara AB; Nair AS; Sung B; Pandey MK; Aggarwal BB
Mol Cancer Res; 2009 Jan; 7(1):118-28. PubMed ID: 19147543
[TBL] [Abstract][Full Text] [Related]
8. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
Seo S; Suh W
Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
[TBL] [Abstract][Full Text] [Related]
10. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
11. YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells.
Zhu M; Liu X; Wang Y; Chen L; Wang L; Qin X; Xu J; Li L; Tu Y; Zhou T; Sang A; Song E
Exp Cell Res; 2018 Dec; 373(1-2):155-163. PubMed ID: 30342005
[TBL] [Abstract][Full Text] [Related]
12. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.
Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322
[TBL] [Abstract][Full Text] [Related]
13. SYVN1 Promotes STAT3 Protein Ubiquitination and Exerts Antiangiogenesis Effects in Retinopathy of Prematurity Development.
Chen S; Zhang J; Sun D; Wu Y; Fang J; Wan X; Li S; Zhang S; Gu Q; Shao Q; Dong J; Xu X; Wei F; Sun Q
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):8. PubMed ID: 37540175
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
[TBL] [Abstract][Full Text] [Related]
15. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.
Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y
Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
Joe SG; Yoon YH; Choi JA; Koh JY
PLoS One; 2015; 10(3):e0119708. PubMed ID: 25785990
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
19. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
